Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
Stock Information for Creative Medical Technology Holdings Inc.
Loading
Please wait while we load your information from QuoteMedia.